Dr. Isabella N. Marlowe, MD, PhD

Professor of Translational Medicine & Clinical Pharmacology
Director, Center for Clinical Trials & Evidence-Based Medicine, London Institute of Medical Research

Professional Summary

Dr. Isabella Marlowe is a distinguished clinician-scientist and academic leader with over 20 years of experience in the design, regulation, and analysis of clinical trials and therapeutic innovations. She has led numerous multinational Phase II-IV studies and has contributed significantly to the advancement of ethical practices in human trials, translational drug research, and therapeutic safety evaluations.

Experience

MD, University of Edinburgh, UK
PhD in Clinical Pharmacology, Karolinska Institutet, Sweden
MSc in Biostatistics, Johns Hopkins University, USA

Education

Former Section Editor, Journal of Experimental Therapeutics
Peer Reviewer for The Lancet, BMJ Open, and Nature Medicine
Member, European Clinical Research Infrastructure Network (ECRIN)

Research Interests

Clinical trial methodology
Novel therapeutic development
Personalized medicine
Regulatory science & patient-centered trial design
AI integration in drug response analytics

Notable Achievements

Published over 100 peer-reviewed articles on therapeutic interventions and trial outcomes
Principal Investigator in over 30 multicenter clinical trials
Led the Therapeutic Integrity Initiative (TII) for transparent trial reporting

Vision for MJCTT

Editor in Chief

Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT)

"My mission is to make MJCTT the most trusted global platform for accelerating ethical, innovative, and impactful clinical research that transforms patient care across diverse populations."

About (MJCTT)

Mogito Open Access Journal of Clinical Trials & Therapeutics (MJCTT) is a peer-reviewed, international, open access journal committed to advancing research in clinical trials, experimental therapeutics, and evidence-based medical innovation. As a key title under the Medicine & Clinical Research category of the Mogito Open Access Journals platform, MJCTT serves as a global forum for academics, clinicians, and industry experts to share high-impact, original findings and critical evaluations that shape the future of therapeutic strategies and patient care.